Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP6 as Adjunctive Treatment for Bipolar Depression
NCT02081287Phase 1Completed
- Sponsor
- VA San Diego Healthcare System
- Start
- May 2014
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of phytic acid in bipolar disorder (BD) (2 arms), sponsored by VA San Diego Healthcare System. Primary endpoint: Depression Severity at 10 weeks. Started May 2014; status: completed.
02
Drugs
phytic acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02081287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02081287.